Cbd

STATE OF THE INDUSTRY SURVEY

NutraIngredients-USA survey on the state of the US Dietary Supplements industry in 2020

02-Dec-2020 By Stephen Daniells

How has Covid-19 affected business? Beyond immunity which categories were big winners in 2020? And did we learn anything about delivery formats this year?

‘Clarity is a good thing…’ Proposed regs on CBD in New York hailed by food & bev brands as ‘pragmatic’ and ‘rational’

30-Oct-2020 By Elaine Watson

Proposed rules regulating the sale of ingestible products containing hemp-derived cannabinoids in New York have been hailed as “pragmatic” and “rational” by brands attempting to navigate the regulatory minefield in the absence of federal regulations.

Hemp Synergistics launches new patent-pending CBD lines

19-Oct-2020 By Danielle Masterson

Hemp Synergistics, a biotech company that develops intelligent hemp products, recently announced the launch of Pure Synergistics and Lily + Rein.

New report finds CBD prices dropped 17% in 2020

07-Oct-2020 By Danielle Masterson

A new comprehensive study of major CBD brands by Leafreport found that in most cases, the price of CBD has decreased.

Congress extends hemp pilot program

01-Oct-2020 By Danielle Masterson

The Senate passed a continuing resolution Wednesday that provides short term funding in a move that will prevent a government shutdown. The resolution also included the House’s language to extend the hemp pilot program through September of 2021.

FDA announces public meeting to discuss gender differences in use and responses to CBD

24-Sep-2020 By Stephen Daniells

The US Food and Drug Administration has announced a virtual public meeting to explore the potential sex (biological) and gender (psychosocial) differences in use and responses to cannabidiol (CBD) and other cannabinoids.

CBD firm and vet group partnership highlight issue of CBD for active military

24-Sep-2020 By Danielle Masterson

Preferred-CBD has teamed up with Veterans Advantage in a move that will give its members access to discounts on CBD products.

NutraVideo: Caliper on finding the right CBD dose

14-Sep-2020 By Danielle Masterson

Representatives Kurt Schrader and Morgan Griffith recently introduced the Hemp and Hemp-Derived CBD Consumer Protection & Market Stabilization Act of 2020.

Nestlé and Geocann bring ultra-bioavailable CBD to Europe

14-Sep-2020 By Nikki Hancocks

Nestlé Health Science and US-based Geocann are bringing their patented VESIsorb high-bioavailability hemp products to Europe, after success in the US.

NutraVideo: Arcadia Biosciences on new developments in hemp breeding, gene editing

09-Sep-2020 By Danielle Masterson

Arcadia Biosciences is a publicly-traded crop innovation company that is pioneering new developments in hemp through plant breeding technology and gene editing.

Trade groups unite to support new Hemp-CBD bill

09-Sep-2020 By Stephen Daniells

Multiple hemp and dietary supplement industry trade groups have written to Reps. Kurt Schrader (D-OR) and Morgan Griffith (R-VA) to thank them for their leadership on the hemp-CBD issue.

Hemp-CBD dietary supplement bill introduced in the House

04-Sep-2020 By Stephen Daniells

Rep. Kurt Schrader (D-OR) and Rep. Morgan Griffith (R-VA) have introduced the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 to allow hemp and hemp derived CBD to be legally marketed in dietary supplements.

Immune health benefits, delivery system innovation characterize August product launches

31-Aug-2020 By Danielle Masterson

The month of August ushered in a variety of new product offerings, with immunity and convenience at the forefront.

AHPA event aims to guide CBD industry

25-Aug-2020 By Danielle Masterson

Products containing cannabidiol (CBD) represent a rapidly growing yet uncertain market segment, with those in the industry often finding themselves with more questions than answers.

CBD industry headed toward big overcapacity, expert asserts

24-Aug-2020 By Hank Schultz

The hemp/CBD industry may have gotten the cart before the horse in terms of extraction capacity and raw material supply, said an investment analyst familiar with the sector.

Hemp groups dial up pressure for federal CBD regulation

21-Aug-2020 By Hank Schultz

Hemp industry groups have been submitting plans to the federal government for regulation of the space, something they say is urgently needed.

The Vitamin Shoppe introduces CBD HQ

18-Aug-2020 By Danielle Masterson

After first debuting CBD products in 2019, The Vitamin Shoppe has announced the launch of its new CBD HQ in-store and online concept.

NutraCast Podcast: Hemp Synergistics introduces ‘Intelligent Hemp Products’

14-Aug-2020 By Danielle Masterson

A Pittsburgh-based biotech company said it is on a mission to develop cutting-edge technology to fill the gaps in the growing and evolving cannabis industry.

What's happening in the UK & EU for CBD?

12-Aug-2020 By Stephen Daniells

With the UK and the European Union now on divergent paths because of Brexit, what is the state of play for regulating hemp and CBD across the pond and where are the opportunities?

Review hints at CBD’s performance enhancing qualities as EC decision awaits

10-Aug-2020 By Will Chu

Cannabidiol (CBD) may have its uses as a performance-enhancer in sports after a review outlines the compound’s role in reducing inflammation and anxiety as well as increasing the quality of sleep.

CV Sciences’ revenue dives, but new products, increased distribution point to brighter future, company says

07-Aug-2020 By Hank Schultz

CBD manufacturer CV Sciences has reported a sharp drop in revenue, but company officials said wider distribution and new launches—including a product that contains no CBD—promise a bright future.

New high capacity Colorado CBD extractor enters market

31-Jul-2020 By Hank Schultz

Vantage Hemp, a new hemp/CBD processor, is entering the market with a high capacity facility nearing completion in Colorado.

July new product offerings: CBD paws its way into the pet sector, micro-shots for kids and more

30-Jul-2020 By Danielle Masterson

From canine mental health to a new krill oil supplement, NutraIngredients-USA has been monitoring the latest products to hit the market.

Is FDA open to entertaining an NDI for CBD products?

30-Jul-2020 By Stephen Daniells

The US Food and Drug Administration may be willing to sit down with a company about a possible NDI submission for full-spectrum hemp extracts, says Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN).

New survey offers insight on the explosion of CBD in the pet space

29-Jul-2020 By Danielle Masterson

AmericanMarijuana.org recently surveyed over 1,000 consumers who give their pets Cannabidiol (CBD). The survey aimed to gauge the attitudes of pet owners, their veterinarians, and what factors influenced their decisions.

Is FTC pushing back on structure/function claims territory, asks UNPA’s Israelsen

27-Jul-2020 By Stephen Daniells

Many recent warning letters from the Federal Trade Commission about COVID-19 are warranted, says UNPA’s Loren Israelsen, but some targeting health practitioners and what our industry has to offer in the broader immunity discussion may hint at redefining...

Amendment to military funding bill would allow soldiers to openly use CBD products

24-Jul-2020 By Hank Schultz

An amendment to a military funding bill would make it possible for military personnel to openly use hemp/CBD products for the first time. While advocates welcome the development, there is little prospect that CBD products will become part of standard...

NPA Fabricant on CBD, NDIs, FDA resuming inspections

24-Jul-2020 By Stephen Daniells

FDA has stated it is making ‘substantial progress’ with CBD, and a new enforcement guidance could be very significant for the industry, said NPA’s Dr Daniel Fabricant, but he said the Agency needs to ‘get in the game’ for NDIs.

Uphill battle for CBD companies registering trademarks

15-Jul-2020 By Danielle Masterson

The United States Trademark Trial and Appeal Board (TTAB) recently issued a precedential decision that would control future rulings on whether a company could register a trademark for a dietary supplement or food containing cannabidiol (CBD).

NutraCast Podcast: Hemp pioneer Richard Rose on CBD, FDA

10-Jul-2020 By Danielle Masterson

On this episode of the NutraCast, we were joined by Richard Rose, who has worked with hemp for decades and is a self-described ‘Hemp OG.” He created the first “open-source” hemp brands Nobacco and Notpot. He has also created CannaSearch, which has opened...

FDA report details poor quality control, undisclosed THC in many CBD products

09-Jul-2020 By Hank Schultz

An FDA report on the CBD marketplace reveals that many of the products tested contain THC that was not identified on the labels. In addition, a majority of the products did not meet label claim for CBD content, with either too little or too much CBD.

CBD and female sexual wellness: An emerging category

08-Jul-2020 By Danielle Masterson

It’s been promoted for relaxation, muscle spasms, depression, gastrointestinal issues, and more. Now, a number of products claim cannabidiol can help in the bedroom.

CBD lawsuits highlight labeling, advertising risks

02-Jul-2020 By Danielle Masterson

As more and more cannabidiol (CBD) products continue to hit the shelves, an increasing number of lawsuits are showing up on dockets.

Healthy Food Ingredients adds CBD to portfolio

02-Jul-2020 By Danielle Masterson

Specialty ingredient supplier Healthy Food Ingredients (HFI) recently announced it has formed a strategic supply partnership with KND Labs to keep up with demand for hemp cannabinoid ingredients.

CBD Novel Foods deadline fast approaching as firms embrace regulatory challenges

02-Jul-2020 By Will Chu

With the UK Food Standards Agency (FSA) setting 31 March 2021 as the deadline for firms to have validated novel foods application for its CBD products, how are firms responding to this challenge especially in the current climate?

CBD body announces safety study consortium as Novel Foods crunch time looms

19-Jun-2020 By Oliver Morrison

Ahead of the UK Food Standards Agency’s 31 March 2021 deadline for CBD products to have a validated novel foods application, the Association for the Cannabinoid Industry (ACI), which works to create a safe, legal and well-regulated CBD market in the UK,...

CRN files petition proposing way forward for CBD supplements; leaves foods/beverages to be dealt with ‘later’

18-Jun-2020 By Elaine Watson

With the regulatory path forward for hemp-derived CBD in foods and supplements no clearer a year after the FDA’s May 2019 public meeting, trade association The Council for Responsible Nutrition (CRN) has filed a citizen’s petition urging the FDA to regulate...

NutraCast Podcast: Why CBD companies need a supplement executive

12-Jun-2020 By Danielle Masterson

For those who want to begin manufacturing cannabidiol (CBD), the process can be overwhelming.

New report suggests “CBD industry is maturing”

11-Jun-2020 By Danielle Masterson

An independent study by Leafreport.com found that Cannabidiol (CBD) products actually contain more CBD than what the label states.

News in brief

Alkemist Labs again achieves ISO 17025:2017 accreditation, adds CBD & terpenes methods

11-Jun-2020 By Stephen Daniells

California-based Alkemist Labs has again achieved accreditation to the requirements of ISO/IEC 17025:2017, but this time the accreditation includes the lab’s internally developed cannabinoids and terpenes assays.

CBD firms team up with CRO to conduct large scale safety study

10-Jun-2020 By Hank Schultz

A group of hemp/CBD purveyors have teamed up with a clinical research firm to conduct a large scale study to provide the safety data that the US Food and Drug Administration says it lacks.

FDA says it’s made ‘substantial progress’ on CBD regs; CV Sciences weighs in on food vs pharma path; man sues CBD firm after failing drugs test

05-Jun-2020 By Elaine Watson

The FDA says it has made “substantial progress” in forging a regulatory path for ingestible CBD products, but has given no indication of when it might provide food and supplement makers with more clarity.

Pet supplements are hot end of already sizzling CBD market

04-Jun-2020 By Danielle Masterson

CBD is skyrocketing in popularity and you don’t have to go far to find it. It’s available online, at CVS and even at your local pet supply store.

Warning letter cites CBD’s regulatory status as leading issue

03-Jun-2020 By Hank Schultz

A recent warning letter to a Colorado dietary supplement formulator has put front and center FDA’s determination that CBD should not be a constituent of dietary supplements.

‘Resonated with investors’: CBD specialist Elixinol raises $11m, pledges branded products focus

03-Jun-2020 By Tingmin Koe

CBD specialist Elixinol Global has managed to hit its capital raising target of AUD$11m (US$7.3m) following a two-stage fund raising exercise, which it believes is a proof of how its CBD supplements have resonated with its investors.

Study: CBD may relieve arthritis in dogs, researchers say follow-up in humans warranted

01-Jun-2020 By Danielle Masterson

CBD may improve joint pain in canines, an animal model of arthritis deemed appropriate for assessing human arthritis pain, according to a new study. The study authors said follow-up investigations in humans are now warranted.

Series of high-profile lawsuits challenging legal status of CBD products are stayed or voluntarily dismissed

29-May-2020 By Elaine Watson

Several high-profile lawsuits challenging the legal status of CBD products have been stayed (effectively put on ice until the FDA outlines a regulatory path forward for CBD in foods & supplements) or voluntarily dismissed in recent weeks.

Post-market surveillance supports safety and tolerability of PlusCBD products

27-May-2020 By Stephen Daniells

Data collected over two years of post-market surveillance offers strong support for the safety and tolerability of PlusCBD products from CV Sciences, with fewer than 0.03% of products producing any kind of adverse event.

‘No CBD isolate’ and ‘zero THC’ claims indicative on ongoing regulatory uncertainty

21-May-2020 By Hank Schultz

New claims creeping into the hemp/CBD space are indicative of the some of the unsolved regulatory issues that continue to distort the market. These include claims of ‘zero THC’ and ‘no CBD isolate.’

Commentary

Research confirming consumers’ confusion points to yawning gap in CBD market surveillance

21-May-2020 By Hank Schultz

The ongoing CBD regulatory logjam has stunted the development of responsible, informative health claims for these products. I’ve speculated in these pages before that this will lead consumers to make it up as they go along. Two new studies seem to confirm...